Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings
| Status: | Completed |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/11/2015 |
| Start Date: | October 2011 |
| End Date: | February 2014 |
| Contact: | Ira J Goldberg, MD |
| Email: | ijg3@columbia.edu |
| Phone: | 212-305-5961 |
Pilot Study Evaluating the Efficacy, Tolerance and Safety of VITAL AF (Semi Elemental, High Protein, High Omega 3 Fat Enteral Formula) Versus Osmolite 1.2 (High Protein Enteral Formula) in Multiple ICU Settings (Medical, Surgical, Cardiothoracic)
The purpose of this pilot study is to assess the efficacy, safety and tolerance profile of
the enteral feeding product VITAL AF (a semi-elemental, high protein, and high omega-3 fish
oil) when compared to Osmolite 1.2, a standard feeding product in critically ill and/or post
surgical patients in the intensive care unit (ICU). If enough patients are recruited,
inferences about impact on outcomes may also be drawn.
the enteral feeding product VITAL AF (a semi-elemental, high protein, and high omega-3 fish
oil) when compared to Osmolite 1.2, a standard feeding product in critically ill and/or post
surgical patients in the intensive care unit (ICU). If enough patients are recruited,
inferences about impact on outcomes may also be drawn.
Inclusion Criteria:
- Subject requires enteral tube feeding as sole source of nourishment
- Subject, or subject's legally acceptable representative (LAR), has provided
voluntarily and informed consent form, as deemed appropriate and approved by the
Columbia University Medical Center Institutional Review Board
- Subject is ≥ 18 years of age
- Subject is male or non-pregnant female at least six weeks postpartum and
non-lactating females of childbearing potential will be required to confirm
non-pregnancy status with a pregnancy test at screening
- Subject has an initial APACHE II score less than or equal to 24
Exclusion Criteria:
- Subject requires parenteral nutrition
- Subject is acutely impacted or constipated
- Subject has intestinal obstruction
- Subject is too hemodynamically unstable for enteral feeding
- Subject has an allergy or intolerance to any ingredient in the study product by
documentation or verbal report by subject or subject's LAR
- Subject is participating in a non-Abbott approved concomitant trial
- Subject has gastrointestinal disease, including acute pancreatitis, active
gastrointestinal bleeding, acute inflammatory bowel disease, or has undergone
intestinal surgery within the past month
We found this trial at
1
site
Click here to add this to my saved trials
